🎀 Breast Nodule Manager · BI-RADS Assessment & Follow-up
UseFollow-up and biopsy triage after an ultrasound or mammography BI-RADS category.
Strata1–2 routine screening, 3 short-interval follow-up, 4–5 tissue biopsy, 6 breast specialist referral. BI-RADS i…
LimitsA benign result discordant with imaging needs re-evaluation. · This page gives no surgical or systemic-therapy plan.
SourceAmerican College of Radiology. ACR BI-RADS Atlas, 5th edition. Reston, VA: ACR; 2013
This-shift next steps
After scoring: open the scene pack, peer scores, and the matching pathway. Local reference — no HIS write.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.
Methodology · worked example, guidelines & full notes
BI-RADS 3: short-interval follow-up.
When to use
Follow-up and biopsy triage after an ultrasound or mammography BI-RADS category.
How it works
BI-RADS likelihood: 1–2 ≈0%; 3 ≤2%; 4A >2–≤10%; 4B >10–≤50%; 4C >50–<95%; 5 ≥95%; 6 pathology-proven.
Key points
- BI-RADS 3: short-interval follow-up.
- BI-RADS 4–5: tissue biopsy.
- Biopsy pathology is the reference standard.
References
- [Guideline / primary source]American College of Radiology. ACR BI-RADS Atlas, 5th edition. Reston, VA: ACR; 2013
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| BI-RADS category (ultrasound/mammography) | 4A low suspicion |
|---|
→BI-RADSBI-RADS 4A low suspicion
- Malignancy likelihood (ACR BI-RADS Atlas, 5th ed., 2013)：>2–≤10%
- Triage：Tissue biopsy recommended.
- Scope：This tool covers BI-RADS assessment and follow-up triage only; surgery and systemic therapy after diagnosis are decided by the breast team per current guidelines.
| BI-RADS category (ultrasound/mammography) | 0 incomplete |
|---|
→BI-RADSBI-RADS 0 incomplete
- Malignancy likelihood (ACR BI-RADS Atlas, 5th ed., 2013)：—
- Triage：Needs additional imaging or comparison with prior studies before a final category.
- Scope：This tool covers BI-RADS assessment and follow-up triage only; surgery and systemic therapy after diagnosis are decided by the breast team per current guidelines.
Verification & sources · governance
FAQ
Frequently asked questions
- Does Breast Nodule Manager · BI-RADS Assessment & Follow-up upload patient data? Where is it calculated?
- Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
- How is Breast Nodule Manager · BI-RADS Assessment & Follow-up calculated in practice? Can you show a worked example?
- Inputs: BI-RADS category (ultrasound/mammography) 4A low suspicion → Result: BI-RADS BI-RADS 4A low suspicion（Malignancy likelihood (ACR BI-RADS Atlas, 5th ed., 2013): >2–≤10%, Triage: Tissue biopsy recommended., Scope: This tool covers BI-RADS assessment and follow-up triage only; surgery and systemic therapy after diagnosis are decided by the breast team per current guidelines.） Inputs: BI-RADS category (ultrasound/mammography) 0 incomplete → Result: BI-RADS BI-RADS 0 incomplete（Malignancy likelihood (ACR BI-RADS Atlas, 5th ed., 2013): —, Triage: Needs additional imaging or comparison with prior studies before a final category., Scope: This tool covers BI-RADS assessment and follow-up triage only; surgery and systemic therapy after diagnosis are decided by the breast team per current guidelines.）